Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 80.18B | 79.93B | 80.45B | 98.95B | 110.24B | 122.81B |
Gross Profit | 55.67B | 62.20B | 61.40B | 72.55B | 81.06B | 93.04B |
EBITDA | 36.47B | 46.23B | 22.89B | 39.39B | 50.57B | 56.77B |
Net Income | 9.74B | 19.11B | 13.73B | 13.65B | 11.34B | 17.34B |
Balance Sheet | ||||||
Total Assets | 219.49B | 229.58B | 218.38B | 239.25B | 225.74B | 256.53B |
Cash, Cash Equivalents and Short-Term Investments | 11.16B | 10.77B | 20.86B | 10.26B | 15.60B | 20.97B |
Total Debt | 95.19B | 101.62B | 102.19B | 118.52B | 131.40B | 150.00B |
Total Liabilities | 139.85B | 147.04B | 147.95B | 174.88B | 194.25B | 212.62B |
Stockholders Equity | 73.82B | 76.62B | 64.48B | 60.13B | 26.29B | 38.32B |
Cash Flow | ||||||
Free Cash Flow | 17.93B | 18.10B | 14.39B | 19.92B | 22.82B | 24.82B |
Operating Cash Flow | 30.49B | 31.48B | 29.12B | 39.22B | 42.27B | 43.82B |
Investing Cash Flow | -12.69B | -11.49B | -18.30B | -23.14B | -17.23B | -10.56B |
Financing Cash Flow | -28.76B | -29.39B | -1.53B | -23.98B | -27.90B | -27.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $16.66B | 11.25 | 16.28% | 6.04% | -5.14% | -7.47% | |
77 Outperform | $18.73B | 18.50 | 7.95% | 1.97% | -5.69% | -0.05% | |
71 Outperform | $21.05B | 22.63 | 12.99% | 5.77% | -2.94% | 30.09% | |
71 Outperform | $53.66B | 32.10 | 8.54% | 3.12% | 0.19% | -49.68% | |
62 Neutral | $40.75B | -1.21 | -12.05% | 3.97% | 2.04% | -69.68% | |
59 Neutral | $29.55B | ― | -0.55% | 4.88% | -2.29% | -182.68% | |
57 Neutral | $26.43B | 9.21 | -7.17% | 4.67% | 0.89% | -494.16% |